Modulation of cis-platinum renal toxicity by the radioprotective agent WR 2721

Choie, 1981, Acute and chronic cisplatin nephropathy in rats, Lab. Invest., 44, 397 Ganote, 1974, The nature of d-serine-induced nephrotoxicity, Amer. J. Pathol., 77, 269 Jordan, 1978, Late effects of radiation on the mouse kidney, Exp. Mol. Pathol., 29, 115, 10.1016/0014-4800(78)90031-X Jordan, 1979, Comparative late effects of x-rays and negative pi-mesons on the mouse kidney, Amer. J. Pathol., 97, 315 Lippman, 1973, Clinical trials of cis-diamminedichloroplatinum (NSC-119875), Cancer Chemother. Rep., 57, 191 Mazze, 1973, Strain differences in metabolism and susceptibility to the nephrotoxic effects of methoxyflurane in rats, J. Pharmacol. Exp. Ther., 184, 481 Rossof, 1972, Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP), Cancer, 30, 1451, 10.1002/1097-0142(197212)30:6<1451::AID-CNCR2820300606>3.0.CO;2-Q Ward, 1976, The nephrotoxic effects of cis-diammine-dichloroplatinum (II) (NSC-119875) in male F 344 rats, Toxicol. Appl. Pharmacol., 38, 535, 10.1016/0041-008X(76)90185-X Yuhas, 1980, A more general role for WR 2721 in cancer therapy, Brit. J. Cancer, 41, 832, 10.1038/bjc.1980.150 Yuhas, 1980, Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum by WR 2721 without altering its anti-tumor properties, Cancer Treat. Rep., 64, 57 Yuhas, 1980, Treatment of tumours with the combination of WR 2721 and cis-dichlorodiamminoplatinum or cyclophosphamide, Brit. J. Cancer, 42, 574, 10.1038/bjc.1980.282 Zbinden, 1969, Experimental renal toxicity, Vol. II